Skip to content

Clinical trials

Lupus Erythematosus, Systemic trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Country / region: Hong Kong Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20061
20072
20083
20091
20102
20112
20122
20133
20191
20201
20223
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated5
Active, not recruiting2
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Anthera Pharmaceuticals3
UCB Pharma3
Amgen2
Bristol-Myers Squibb2
Chinese University of Hong Kong2
GlaxoSmithKline2
Human Genome Sciences Inc., a GSK Company2
Novartis Pharmaceuticals2
AstraZeneca1
Human Genome Sciences Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic25
Autoimmune Diseases8
Lupus Nephritis6
Nephritis4
Glomerulonephritis3
Arthritis1
Arthritis, Rheumatoid1
Atherosclerosis1
Connective Tissue Diseases1
Dermatomyositis1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.